Literature DB >> 2443730

The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA.

M T Hierowski1, M W McDonald, L Dunn, J W Sullivan.   

Abstract

Growth factors stimulating DNA synthesis in mouse 3T3, human DU145, and LNCaP were partially purified from human benign hyperplastic and cancerous prostates. These factors have a high affinity for heparin sepharose and are eluted from the heparin-sepharose column, at 1.2 to 1.9 M NaCl. In normal prostates, the high affinity human prostatic growth factor occurred only in extremely small amounts. The high affinity growth factors stimulate DNA synthesis in 3T3, DU145, and LNCaP. Stimulation was significantly enhanced by 5 alpha-dihydrotestosterone and 17 beta-estradiol in the androgen sensitive LNCaP cell line. SDS-PAGE and isoelectrofocusing confirmed that the partially purified factors had a molecular weight of 18 kDa and acidic isoelectric points of pH 3.6 and 4.7.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443730     DOI: 10.1016/s0022-5347(17)43414-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Partial purification and characterization of a growth factor from human hyperplastic prostatic tissues.

Authors:  A Dignass; A W Holldorf
Journal:  Urol Res       Date:  1992

Review 2.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

3.  Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines.

Authors:  F K Asadi; R Sharifi
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

4.  LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.

Authors:  K S Hirsch; C D Jones; J E Audia; S Andersson; L McQuaid; N B Stamm; B L Neubauer; P Pennington; R E Toomey; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.